←
Dale Vimalachandran2,877 posts
Dale Vimalachandran avatar

Dale Vimalachandran

@dalevim

GI surgeon and researcher

◷ Joined February 2012▧ 180 Photos and videos
Samir Pathak avatar
⟳ Dale Vimalachandran retweeted
Samir Pathak@Drsampathak·15 Sep 2025

Enjoyed doing this with @JohnRTMonsonMD - A challenging but very enjoyable journey so far. From being born with an absent right fibula to playing for England Universities at cricket, to being told I lack the intelligence to complete a higher degree to SSL for pancreatic surgery

#Surgeonslives is back! #stuffthatmatters We go to the UK and talk to @Drsampathak about #Surgery #Cricket #racism and #Charity Here is a clip but click on the link to watch the full interview youtu.be/f6qzhPfAqP8 @MCCOfficial @UniversityLeeds @asgbi @ALSGBandI

1:30
Simon Buczacki avatar
⟳ Dale Vimalachandran retweeted
Simon Buczacki@SiBucz·3 Sep 2025

linkedin.com/posts/cancer-re… We're humbled to have been awarded a CRUK Programme Foundation Award to further progress our work on mutational order in cancer. New post-doctoral positions in our group to be advertised shortly. @NDSurgicalSci @OxfordCancer

@ACPGBI avatar
⟳ Dale Vimalachandran retweeted
@ACPGBI@ACPGBI·12 Aug 2025

🚀 Got a Research Idea? Don’t Keep It to Yourself! Get expert feedback on: Design 🧩 PPI 💬 Funding 💷 Infrastructure 🏗️ Any topic. Any stage. Small to large. Early to mature. 📥 Submit 250 words to hsekhar1982@gmail.com to book your slot @hsekhar1982 @kjadams_surg

Post attachment
OCathail.SM avatar
⟳ Dale Vimalachandran retweeted
OCathail.SM@OcathailS·2 May 2025

Looking forward to hearing @C_Roxburgh present our PRIME RT trial results #ESTRO2025...exciting times in rectal radiation ! @UofGlasgow

📢 Don’t miss the Green Journal–Lancet Oncology joint plenary at #ESTRO2025! 🗓 Sun May 4 | ⏰ 11:40–12:45 📍 Plenary Hall Top clinical trials in GI & SBRT from 🇬🇧 🇳🇱 🇨🇳 — including PLATO ACT 4, STAR-TREC, PRIME-RT & more. #Radiotherapy #Oncology #GreenJournal

Ville Sallinen avatar
⟳ Dale Vimalachandran retweeted
Ville Sallinen@villesallinen·10 Apr 2025

LASER trial 4-year results @JAMASurgery! Sigmoid resection vs conservative treatment for recurrent diverticulitis: No difference in QOL or complications Recurrences 16% vs 92% BUT, 32% crossed conservative>surgery (pts w low QOL). Interpretation🤔: Surgery for pts w low QOL

Post attachment
Rajarshi Mukherjee avatar
⟳ Dale Vimalachandran retweeted
Rajarshi Mukherjee@RishiMukher·23 Jan 2025

Delighted to be awarded the first @The_MRC / @GSK Clinician Scientist Fellowship as part of the innovative MRC Medicines Development Scheme led by @LivUni to use AI-driven drug discovery approaches to develop new treatments for inflammation induced lung injury and ARDS.

A Consultant Surgeon in Emergency General & Major Trauma at UHLG has been awarded a £2M Clinical Scientist award by the @The_MRC and GlaxoSmithKline 👏 This is part of a Development Fellowship scheme, supporting research into emergency medicine. More: bit.ly/40rBADJ

Post attachment
Aneel Bhangu avatar
⟳ Dale Vimalachandran retweeted
Aneel Bhangu@aneelbhangu·26 Dec 2024

Our clinical PhD programme, focussed on surgeons-in-training, is central to our research strategy and the future of surgery in the UK, EU, and rest of the world. We take quality over quantity, give a hands on approach, and build future research leaders. We're advertising for 2 new posts to start October 2025, to start tackling: -the intersection of technology and greener healthcare -addressing data driven knowledge gaps to impact on how governments view surgery -generating data and evidence syntheses to impact on pandemic preparedness in surgery -strengthening supply chains around the world, for both environment sustainability and the delivery of minimally invasive surgery in the Global South -reducing deaths after major surgery -trends analysis in surgery edzz.fa.em3.oraclecloud.com/…

Post attachment